Slide 1: 1H FY23 Results
1H FY23 Results Presenters 31 August 2023 Dr German Arango, CEO Reena Minhas, CFO
Slide 2: Agenda
Agenda 1H FY23 Results 1. IMEXHS Overview 2. Results Overview 3. Financials 4. Strategy & Outlook 2
Slide 3: Overview
imexHSs Overview
Slide 4: One Company with two businesses aimed at democratising access to medical expertise
One Company with two businesses aimed at democratising access to medical expertise Medical Imaging Software Radiology Services Provider of innovative, cloud-based, Outsourcing of imaging facilities AI medical imaging software and teleradiology to hospitals and solutions medical facilities 4
Slide 5: Global footprint
Global footprint Software 18 countries; 461 sites 3,184 radiologists 35 distributors in 15 countries Radiology Colombia, Spain and Mexico 35 radiology centres 150+ in-house radiologists 5
Slide 6: 1H FY23 Results Overview
imexHs 1H FY23 Results Overview
Slide 7: Business Highlights
Business Highlights • The Company has demonstrated the scalability of the business across different geographies with an attractive product and disruptive business model and now is focused in generating positive earnings and cashflow. • Focus is on sales within Latin America and those product develop
Slide 8: 1H FY23 Operational Highlights
1H FY23 Operational Highlights • New radiology services contract • Post the end of first half, the company signed with Famisanar in March 2023, announced it had signed a 5-year Colombia’s fifth largest insurance Software as a Service (SaaS) contract with provider, with $1.1m in ARR. with Grupo Avida
Slide 9: 1H FY23 Financial Highlights
1H FY23 Financial Highlights Sales Revenue Annual Recurring Underlying Revenue (ARR) EBITDA1 Down 7% yoy $8.8m Up 19% yoy $24.4m Up $0.9m vs pcp $0.5m Down 2% on a Up 15% on a constant constant currency currency basis basis2 Recurring Closing cash Debt revenue 97% of total revenue $8.6m vs $1.9m at
Slide 10: FY23 Business Unit Results
FY23 Business Unit Results • Software primarily relates to sales of $M Software Radiology Corporate Total IMEXHS Enterprise and growing IMEXHS Cloud business ➢ Revenue up 25% yoy Revenue 3.5 5.3 - 8.8 ➢ ARR up 22% Underlying • Radiology includes RIMAB along with 1.3 0.2 (1.0) 0.5 EBITDA other servic
Slide 11: Software IMEXHS Enterprise + Cloud
Software IMEXHS Enterprise + Cloud • In 1H FY23: • Focus on ideal client profile and larger customers. ➢ over 4m studies (712m images) processed • Post half-year, a new material contract was signed with Avidanti/Zentria with ➢ over 1.33m people entered IMEXHS's ARR of $434.000. patient portal • Stro
Slide 12: Radiology Services
Radiology Services • Outsourced radiology services for hospitals and other establishments ➢ includes administration, technicians, enterprise software, training, equipment if required; radiologists located on premise and internal teleradiology. 35 Radiology Centres ➢ 95%+ of revenues. • Teleradiology
Slide 13: Product and Software Updates - H1 FY23
Product and Software Updates - H1 FY23 ● Outline of IMEHX's improved value proposition, ● Universal Viewer v6.2 Enhancements based on 3 key pillars ○ Tomosynthesis, dynamic and diffusion studies ○ 24/7 service, support and active monitoring visualization with improved loading times. that exceeds ind
Slide 14: 1H FY23 Financials
imexHs 1H FY23 Financials
Slide 15: Progress in ARR
Progress in ARR ARR as at 30 June 2023 • $24.4m = $14.0m from Radiology Services and $10.4m from Software • Software ARR includes $3.9m from 176 IMEXHS Cloud contracts and $6.5m from IMEXHS Enterprise. 15
Slide 16: Income Statement
Income Statement #039;000 1H FY23 1H FY22 Var Var % • Revenue of $8.8m, with 97% recurring revenue Revenue 8,804 9,462 (658) (7%) • $3.5m from Software and Other revenue 76 133 (57) (43%) • $5.3m from Radiology Services Total revenue 8,880 9,595 (715) (7%) • Underlying EBITDA of $0.5m up Expenses (11,0
Slide 17: Balance Sheet
Balance Sheet #039;000 Jun 23 Dec 22 Jun 22 Cash 1,966 1,912 856 • Closing cash balance of $2.0m as at Trade & other receivables 7,467 6,503 7,286 30 June 2023 and Net Assets of $16.7m. Inventories 112 97 78 Current assets 9,545 8,511 8,220 • Intangible assets include Goodwill of Trade & other receivab
Slide 18: Summary Cash Flow
Summary Cash Flow #039;000 1H FY23 1H FY22 • Closing cash balance of $2.0m as at 30-Jun-23 Net cash from (used) in operating activities 1,410 (1,301) • Net cash from operating activities of $1.4m Net cash used in investing activities (1,026) (1,544) • Debt of $0.4m repaid during 1H FY23 and no new debt
Slide 19: Strategy & Outlook
imexHs Strategy & Outlook
Slide 20: FY23 Outlook
FY23 Outlook FY22 guidance • FY23 Revenue expected to be • Robust growing pipeline. between $19.0m to $20.5m (vs $17.1m in FY22). • New value proposition is under design and planning. This implies: • Marginal increase in development • 2H FY23 expected Revenue investment. growth of 16% - 33% versus 1
Slide 21: Disclaimer
Disclaimer The information contained in this Presentation or subsequently provided to the Recipient of this Presentation, whether orally or in writing by or on behalf of ImExHS Limited or its respective employees, agents or consultants (“Information”) is provided to the Recipient on the terms and co
Slide 22: 1H FY23 Results
1H FY23 Results 31 August 2023